Data analytics platform developer Starburst raised $250m in a Salesforce-backed round valuing it above $3.3bn while SoftBank co-led a $140m round for small molecule drug developer Ventus.
Funding
Enterprise software producer Salesforce took part in a $250m series D round for US-headquartered data analytics software provider Starburst yesterday through subsidiary Salesforce Ventures. Investment adviser Alkeon Capital Management led the round, which valued the company at $3.35bn and which also featured Altimeter Capital Management, B Capital Group, Andreessen Horowitz, Coatue Management and Index Ventures.
Canada-based small molecule drug developer Ventus Therapeutics completed a $140m series C round yesterday co-led by telecommunications and internet group SoftBank’s Vision Fund 2, which is acquiring a board seat that will be taken by investment director John Cassidy. RA Capital Management co-led the round, which included internet and technology group Alphabet’s GV unit, real estate investment trust Alexandria Real Estate Equities’ Alexandria Venture Investments fund, Qatar Investment Authority, Andreessen Horowitz, BVF Partners, Casdin Capital, Cormorant Asset Management, Fonds de solidarité FTQ and Versant Ventures.
Bertelsmann Investments, a vehicle for media group Bertelsmann, joined…
